Results 11 to 20 of about 462,488 (300)

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor

Vascular Health and Risk Management, 2010
Margaret M Marczewski1, Marek Postula1,2, Dariusz Kosior111st Chair and Department of Cardiology, Central University Hospital, Medical University of Warsaw, Warsaw, Poland; 2Department of Experimental and Clinical Pharmacology, Medical University of ...
Margaret M Marczewski, Marek Postula, Dariusz Kosior   +2 more
doaj   +1 more source

A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives

Frontiers in Pharmacology, 2021
Nowadays, nitrogenous heterocyclic molecules have attracted a great deal of interest among medicinal chemists. Among these potential heterocyclic drugs, benzimidazole scaffolds are considerably prevalent.
Shejuti Rahman Brishty, Md. Jamal Hossain, Mayeen Uddin Khandaker, Mohammad Rashed Iqbal Faruque, Hamid Osman, S. M. Abdur Rahman   +5 more
doaj   +1 more source

Evaluation of the Potentially Inappropriate Cardiovascular Medication Prescription in Elderly: A Nationwide Study in Turkey

Anatolian Journal of Cardiology, 2023
Background: Elderly comprises a specific group due to possible alterations in the effects of drugs and comorbidities. We aimed to identify for the first time the characteristics and rates regarding the inappropriate prescriptions of cardiovascular system
Mehmet Tevfik Kitapçı, Osman Karakuş, Fatma İşli, Mesil Aksoy, Muhammed Cihan Güvel, Canan Uluoğlu   +5 more
doaj   +1 more source

Closed-Loop Vagus Nerve Stimulation for the Treatment of Cardiovascular Diseases: State of the Art and Future Directions [PDF]

, 2022
The autonomic nervous system exerts a fine beat-to-beat regulation of cardiovascular functions and is consequently involved in the onset and progression of many cardiovascular diseases (CVDs).
Recchia, Fabio A., Micera, Silvestro, Vallone, Fabio, Ottaviani, Matteo Maria   +3 more
core   +1 more source

Persistence and Adherence to Cardiovascular Medicines in Australia

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa, Jialing Lin, Sallie‐Anne Pearson, Nicholas A. Buckley, Andrea L. Schaffer, Michael O. Falster   +5 more
doaj   +1 more source

Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma

Clinical Epidemiology, 2018
Erzsébet Horváth-Puhó,1 Marit M Suttorp,2 Henrik Frederiksen,1,3 Tiny Hoekstra,2 Olaf M Dekkers,1,2 Lars Pedersen,1 Suzanne C Cannegieter,2 Friedo W Dekker,2 Henrik Toft Sørensen1 1Department of Clinical Epidemiology, Aarhus ...
Horváth-Puhó E, Suttorp MM, Frederiksen H, Hoekstra T, Dekkers OM, Pedersen L, Cannegieter SC, Dekker FW, Sørensen HT   +8 more
doaj   +1 more source

Challenges in the treatment of hypotension in an extremely preterm neonate [PDF]

Srpski Arhiv za Celokupno Lekarstvo
Introduction. Hypotension is often seen in preterm neonates, as a result of various factors such as immature myocardium, transitional circulation, perinatal hypoxia, positive-pressure ventilation, and relative adrenal insufficiency. The leading causes of
Palić Ilija, Jovanović-Krišulović Biljana, Jovičić Marija, Kostić-Todorović Miroslava   +3 more
doaj   +1 more source

2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry [PDF]

, 2015
Objectives: Specifically we aim to demonstrate that the results of our earlier safety data hold true in this much larger multi-national and multi-ethnical population.
Pilz, G., Nothnagel, D., Schneider, S., Sechtem, U, Sechtem, U., Pilz, G, van Rossum, AC, Nagel, E, Greulich, S., Rossum, A.C., Buss, Sebastian, Schwitter, J., Lombardi, M., Greulich, S, Lombardi, M, Wagner, A, Wagner, A., Bruder, O, Buss, S, Mahrholdt, H, Nothnagel, D, Bruder, O., Schwitter, J, Petersen, S., Jensen, C., Jensen, C, Buss, S., Mahrholdt, H., Nagel, E., Schneider, S, van Rossum, A.C., Petersen, S   +31 more
core   +1 more source

Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data. [PDF]

, 2011
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events and mortality in patients using diabetes medication. The General Practice Research Database was used to identify inception cohorts of insulin and different
Van Staa, Tjeerd; id_orcid, Leufkens Hubert G. M., Leufkens, Hubert G M, van Staa Tjeerd P., Hubert G M Leufkens, Gallagher, Arlene M, Leufkens, Hubert GM, Smeeth Liam, Suzie Seabroke, Tjeerd P van Staa, Liam Smeeth, Seabroke Suzie, Smeeth, Liam, Arlene M Gallagher, Seabroke, Suzie, Arlene M. Gallagher, Gallagher Arlene M., van Staa, Tjeerd P, Hubert G. M. Leufkens, Tjeerd P. van Staa   +19 more
core   +1 more source

Natural AMPK Activators in Cardiovascular Disease Prevention

Frontiers in Pharmacology, 2022
Cardiovascular diseases (CVD), as a life-threatening global disease, is receiving worldwide attention. Seeking novel therapeutic strategies and agents is of utmost importance to curb CVD.
Reza Heidary Moghaddam, Zeinab Samimi, Sedigheh Asgary, Pantea Mohammadi, Soroush Hozeifi, Fatemeh Hoseinzadeh‐Chahkandak, Suowen Xu, Mohammad Hosein Farzaei, Mohammad Hosein Farzaei   +8 more
doaj   +1 more source